Evaluation of the catabolic activity of cartilage by measurement of serum keratan sulfate concentration in foals

American Journal of Veterinary Research

Volumn 58, Issue 8, 1997, Pages 925-929

  Okumura, Masahiro ^a   Fujinaga, Toru ^a   Urakawa, Etsuko ^a   Tagami, Masaaki ^b   Tsukiyama, Katsuji ^b  

^a HOKKAIDO UNIVERSITY   (Japan)

^b Shadai Horse Clinic   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

KERATAN SULFATE;

ANIMAL TISSUE; ARTICLE; CARBOHYDRATE ANALYSIS; CARTILAGE; CATABOLISM; ENZYME ACTIVITY; ENZYME ANALYSIS; HORSE; NONHUMAN; QUANTITATIVE ASSAY;

AGING; ALKALINE PHOSPHATASE; ANIMALS; BIOLOGICAL MARKERS; CARTILAGE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HORSES; JOINTS; KERATAN SULFATE; MALE; OSTEOBLASTS; SEX CHARACTERISTICS;

ANIMALIA; EQUUS CABALLUS;

EID: 0030793227     PISSN: 00029645     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Fisher AT, Barclay WP. Osteochondrosis dissecans in the horse. Compend Contin Educ Pract Vet 1984;6:123-131.
2. Heinegard D, Paulsson M. Structure and metabolism of proteoglycans. In: Piez KA, Reddi AH, eds. Extracellular matrix biochemistry. New York: Elesevier Publications BV, 1984;277-328.
3. Maroudas A. Biophysical chemistry of cartilaginous tissues with special reference to solute and fluid transport. Bioreology 1975; 12:233-248.
4. Revell PA, Muir H. The excretion and degradation of chondroitin 4-sulfate administered to guinea pigs as free chondroitin sulfate and as proteoglycan. Biochem J 1972;130:597-606.
5. Thonar EJ-MA, Lenz ME, Klintworth GK, et al. Quantification of keratan sulfate in blood as a marker of cartilage catabolism. Arthritis Rheum 1985;28:1367-1376.
6. Heinegard D, Inerot S, Wieslander J, et al. A method for the quantification of cartilage proteoglycan structures liberated to the synovial fluid during developing degenerative joint disease. Scand J Clin Lab Invest 1985;45:421-427.
7. Saxone T, Heinegard D, Wollheim FA. Therapeutic effects on cartilage metabolism in arthritis as measured by release of proteoglycan structures into the synovial fluid. Ann Rheum Dis 1986;45: 491-497.
8. Block JA, Schnitzer TJ, Andersson GBJ, et al. The effect of chemonucleolysis on serum keratan sulfate levels in humans. Arthritis Rheum 1989;32:100-104.
9. Calatroni A, Donnely PV, DiFerrante N. The glycosaminoglycans of human plasma. J Clin Invest 1969;48:332-343.
10. Kliner DJ, Gorski JP, Thonar, EJ-MA. Keratan sulfate levels in sera of patients bearing cartilage tumors. Cancer 1987;59:1931-1935.
11. Axelsson I, Heinegard D. Characterization of the keratan sulfate proteoglycans from bovine corneal stroma. Biochem J 1978; 169:517-530.
12. Poole AR, Witter J, Roberts N, et al. Inflammation and cartilage metabolism in rheumatoid arthritis. Studies of the blood markers, hyaluronic acid, orosomucoid, and keratan sulfate. Arthritis Rheum 1990;33:790-799.
13. Sweet MBE, Coelho A, Schnitzler CM, et al. Serum keratan sulfate levels in osteoarthritis patients. Arthritis Rheum 1988;31:648-652.
14. Caterson B, Christner JE, Baker JR. Identification of a monoclonal antibody that specifically recognizes corneal and skeletal keratan sulfate. Monoclonal antibodies to cartilage proteoglycan. J Biol Chem 1983;258:8848-8854.
15. Alwan WH, Carter SD, Bennett D, et al. Cartilage breakdown in equine osteoarthritis: measurement of keratan sulphate by an ELISA system. Res Vet Sci 1990;49:56-60.
16. Leipold HR, Goldberg RL, Lust G. Canine serum keratan sulfate and hyaluronate concentrations. Relationship to age and osteoarthritis. Arthritis Rheum 1989;32:312-321.
17. Mehraban F, Finegan CK, Moskowitz RW. Serum keratan sulfate. Quantitative and qualitative comparisons in inflammatory versus noninflammatory arthritides. Arthritis Rheum 1991;34:383-392.
18. Todhunter RJ, Yeager AE, Freeman KP, et al. Keratan sulfate as a marker of articular cartilage catabolism and joint treatment in ponies. Am J Vet Res 1993;54:1007-1016.
19. Farndale RW, Sayers CA, Barrett AJ. A direct spectrophotometric microassay for sulfated glycosaminoglycans in cartilage cultures. Connect Tissue Res 1982;9:247-248.
20. Arican M, Carter SD, Bennett D, et al. Measurement of glycosaminoglycans and keratan sulphate in canine arthropathies. Res Vet Sci 1994;56:290-297.
21. Saxone T, Heinegard D, Wollheim FA, et al. Difference in cartilage proteoglycan level in synovial fluid in early rhumatoid arthritis and reactive arthritis. Lancet 1985;2:127-128.
22. Witter J, Roughley PJ, Webber C, et al. The immunologic detection and characterization of cartilage proteoglycan degradation products in synovial fluids of patients with arthritis. Arthritis Rheum 1987;30:519-529.
23. Poole AR, Ionescu M, Swan A, et al. Changes in cartilage metabolism in arthritis are reflected by altered serum and synovial fluid levels of the cartilage proteoglycan aggrecan. Implications for pathogenesis. J Clin Invest 1994;94:25-33.
24. Lust G, Summers BA. Early, asymptomatic stage of degenerative joint disease in canine hip joints. Am J Vet Res 1981;42:1849-1855.
25. Pickrell JA, Schluter SJ, Belasich JJ, et al. Relationship of age of normal dogs to blood serum constituents and reliability of measured single values. Am J Vet Res 1974;35:897-903.
26. Kramer JW, Sleight SD. The isoenzymes of serum alkaline phosphatase in cats. Am J Vet Clin Pathol 1968;2:87-91.
27. Blackmore DJ, Elton D. Enzyme activity in the serum of thoroughbred horses in the United Kingdom. Equine Vet J 1975;7: 34-39.